Glucagon‐Like Peptide‐1 Receptor Agonists as Adjunctive Therapy for Hidradenitis Suppurativa in Patients With Overweight/Obesity: A Narrative Review of Efficacy, Safety, and Quality‐of‐Life Outcomes

Documents similaires

• The influence of social media on public attitudes and behaviors towards cosmetic dermatologic procedures and skin care practices: A study in Saudi Arabia
  par: Almuntsrbellah Almudimeegh, et autres
  Publié: (2024)
• Occipital Extracranial Dermoid Cyst in a Neonate With Cardiofaciocutaneous Syndrome Type 4 ( CFC4 ): A Case Report
  par: Mona Alkallabi, et autres
  Publié: (2026)
• Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Reduced Disease Severity and Pain in Hidradenitis Suppurativa: A Retrospective Study
  par: Zahidul Islam, et autres
  Publié: (2025)
• Extensive Type V Truncal Aplasia Cutis Congenita in a Surviving Twin With Fetus Papyraceus : A Case Report
  par: Assaf Ghallab Alharbi, et autres
  Publié: (2026)
• Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery
  par: Zayed Rashid, et autres
  Publié: (2025)